ArticleIJU case reports2020
Progressive plasmacytoid variant bladder cancer with retroperitoneal dissemination: An autopsy case report.
Article in IJU case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 11 citations in OpenAlex.
- Plasmacytoid urothelial carcinoma of the urinary bladder with colorectal metastasis and mimicking colitis: A case report.World journal of clinical cases · 2025Article
- Case report series: Pembrolizumab and enfortumab vedotin in plasmacytoid urothelial carcinoma.Frontiers in oncology · 2025Article
- Article
- Renal pelvis cancer with initial symptoms of malignant gastric outlet obstruction.IJU case reports · 2023Article
- Pathological complete response of plasmacytoid variant bladder cancer to pembrolizumab following genomic analysis.IJU case reports · 2022Article
- Clinically undetected plasmacytoid urothelial carcinoma of the urinary bladder with non-mass-forming metastases in multiple organs: an autopsy case.Journal of pathology and translational medicine · 2022Article
- Outcomes of poorly differentiated and plasmacytoid variant bladder urothelial carcinoma.BJUI compass · 2022Article
- Editorial Comment to Progressive plasmacytoid variant bladder cancer with retroperitoneal dissemination: An autopsy case report.IJU case reports · 2020Article
- Progressive plasmacytoid variant bladder cancer with retroperitoneal dissemination: An autopsy case report.IJU case reports · 2020Article
- Poor Outcome due to the Plasmacytoid Variant of Urothelial Carcinoma.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPlasmacytoid urothelial carcinoma is a rare and aggressive variant of bladder cancer. CASE PRESENTATION: A 75-year-old woman presented with plasmacytoid urothelial carcinoma with retroperitoneal dissemination was treated with chemotherapy. After an unsuccessful first-line chemotherapy with gemcitabine and cisplatin, we assessed circulating tumor cells; one such cell was found to be positive for programmed death-ligand 1. The patient received second-line chemotherapy with pembrolizumab. However, the tumor extended to the retroperitoneal organs, and the patient eventually died. Autopsy revealed a widespread diffuse scirrhous infiltration of the carcinoma into the retroperitoneum. However, distant metastasis was not observed.
conclusionThe evaluation of circulating tumor cells and autopsy revealed a disease state of progressive plasmacytoid urothelial carcinoma treated with pembrolizumab.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.